Table 1.

Characteristics of study participants at time of blood specimen collection, Federated States of Micronesia (FSM), and Republic of the Marshall Islands (RMI), 2009–2011.

	FSM (N=33)	RMI (N=17)	Total (N=50)
Characteristic
Age (years), mean±SD	8·5 ± 3·7	11·0 ± 4·8	9·3 ± 4·2
≤ 5 years, n (%)	10 (30)	3 (18)	13 (26)
5 – <11 years, n (%)	12 (36)	4 (24)	16 (32)
11 – 17 years, n (%)	11 (34)	10 (59)	21 (42)
Weight (kg), mean±SD	26·2 ± 9·2	34·9 ± 17·2	29·2 ± 13·1
Height (m), mean±SD	1·18 ± 0·20	1·31 ± 0·28	1·23 ± 0·24
Gender, n (%)
Male	17 (52)	9 (53)	26 (52)
Female	16 (49)	8 (47)	24 (48)
Food intake 1–3 hours before, n (%)
Yes	29 (91)	12 (71)	41 (84)
No	3 (9)	5 (29)	8 (16)
Participant status, n (%)
Case	8 (24)	0 (0)	8 (16)
Contact (all)	25 (76)	17 (100)	42 (84)
Drug regimen, n (%)
Levofloxacin	17 (52)	0 (0)	17 (35)
Levofloxacin/Ethambutol	8 (24)	17 (100)	32 (65)
MDR regimen	8 (24)	0 (0)	8 (24)